Dasatinib in Treating Patients With Stage IV Pancreatic Cancer

NCT00544908 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped Toxicity

Conditions

Pancreatic Cancer

Interventions

DRUG: dasatinib
OTHER: immunoenzyme technique
OTHER: immunohistochemistry staining method
OTHER: laboratory biomarker analysis
PROCEDURE: quality-of-life assessment

Sponsor

City of Hope Medical Center

Collaborators

[object Object]